CDTI ranks Pharmacelera in the top 5% most innovative companies
The Center for the Development of Industrial Technology ranks Pharmacelera in the top 5% most innovative companies of 2016 and, as such,
The Center for the Development of Industrial Technology ranks Pharmacelera in the top 5% most innovative companies of 2016 and, as such,
Pharmacelera has been selected as one of the finalists of the Startup Challenge 2016 program organized by the Pistoia Alliance! This is
After receiving the Seal-Of-Excellence from the European Union SME Instrument program under the umbrella of the H2020 framework, Pharmacelera has been awarded
Pharmacelera’s CEO, Enric Gibert has been selected as member of the Industrial Advisory Committee (IAC) of PRACE. This membership is aligned with
Pharmacelera has been selected to participate in the “Taller Estratégico de Acceleración” (TEA) program, organized by IESE Business School and Acció. The
Pharmacelera was one of the 21 companies selected this year to present at the 2nd Catalunya Emprèn congress, the reference event for
Pharmacelera has been selected to participate in the EMPENTA program, organized by ESADE and Acció. The fourth edition of the Empenta Program